A General Stochastic Volatility Model for the Pricing of Interest Rate Derivatives
, 2007 Anders B. Trolle, Eduardo S. Schwartz
openalex +1 more source
Next‐generation proteomics improves lung cancer risk prediction
Molecular Oncology, EarlyView.This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Chaos control and sensitivity analysis of climate change under green gases and carbon omission utilizing caputo fractional operator. [PDF]
Sci RepAhmad A +5 more
europepmc +1 more source
Rise and Fall of Interest Rate Futures in Indian Derivative Market
, 2014 Pradiptarathi Panda, M. Thiripalraju
openalex +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
Molecular Oncology, EarlyView.This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Anticancer activity mechanism of novelly synthesized and characterized benzofuran ring-linked 3-nitrophenyl chalcone derivative on colon cancer cells. [PDF]
Open Med (Wars)Oztepe M, Coskun D, Ari F.
europepmc +1 more source
Use of Forward Interest Rates and Forward Exchange Rates for the Valuation of Currency-Interest Rate Derivatives [PDF]
, 2014 Jaroslav Brada
openalex +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
Molecular Oncology, EarlyView.WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Discriminating Interference Fading Locations in Φ-OTDR Using Improved Density Clustering Algorithm. [PDF]
Sensors (Basel)Tao H +6 more
europepmc +1 more source